• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number VBJR060502A
Device Problem Device-Device Incompatibility (2919)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/26/2020
Event Type  malfunction  
Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on october the patient presented for sfa occlusive disease.During the procedure a gore® viabahn® endoprosthesis snagged on a previously placed stent (brand unknown) and began to partially pre-deploy.The device was removed from the patient.Another gore device was used to complete the procedure.The patient tolerated the procedure.
 
Manufacturer Narrative
Engineering evaluation: the manufacturing records were reviewed and the device lot met all pre-release specifications.The physical investigation of the device confirmed the physician¿s observation that the zipper was partially deployed.It did not confirm the observation that the endoprosthesis had expanded.The root cause for the partially deployed zipper is consistent with interaction with a previously implanted device.
 
Manufacturer Narrative
This report was initially sent as a reportable malfunction, due to the stent graft being reported as partially expanded.However, the device was returned to gore for engineering evaluation.The engineering evaluation did not confirm, the observation that the endoprosthesis had expanded.As a result this medwatch will be retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10857073
MDR Text Key222936620
Report Number2017233-2020-01452
Device Sequence Number1
Product Code NIP
UDI-Device Identifier00733132623952
UDI-Public00733132623952
Combination Product (y/n)Y
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 08/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/01/2023
Device Model NumberVBJR060502A
Device Catalogue NumberVBJR060502A
Was Device Available for Evaluation? Yes
Date Manufacturer Received08/30/2021
Patient Sequence Number1
-
-